Wu Kenneth K, Huan Youming
Department of Cardiovascular Disease, Merck Research Laboratories, RY 80W-250, 126 East Lincoln Avenue, Rahway, NJ 07065, USA.
Atherosclerosis. 2007 Apr;191(2):241-9. doi: 10.1016/j.atherosclerosis.2006.08.030. Epub 2006 Sep 18.
Coronary heart disease (CHD) due to atherosclerosis is the leading cause of death in the USA, and accelerated CHD has emerged as a leading cause of morbidity and mortality in diabetic patients in the USA and worldwide. This has highlighted the importance and urgency of studying the mechanism of diabetic atherosclerosis and exploring therapeutic options. Due to its unique advantages over other animal models, the mouse is the most used model for studying the mechanism of diabetes-accelerated atherosclerosis and exploring effective therapeutic approaches. In the past decade, several diabetic atherosclerosis mouse models have been established. Currently, however, there is no ideal animal model for diabetic atherosclerosis. To determine the characteristics of the models that more closely resemble human diabetic atherosclerosis disease, this review focuses on the common diabetic atherosclerosis mouse models with respect to the following issues: (1) whether the mice retain diabetic condition; (2) whether the diabetes accelerates atherosclerosis or increases atherogenic inflammation; (3) whether these factors respond to medical interventions. The discussion is aimed at identifying different diabetic mouse models and their features, in order to heighten awareness of the appropriate models that may provide useful tools for studying the mechanism of diabetes-accelerated atherosclerosis and evaluating therapeutic options.
动脉粥样硬化所致冠心病是美国的首要死因,而加速性冠心病已成为美国及全球糖尿病患者发病和死亡的主要原因之一。这凸显了研究糖尿病性动脉粥样硬化机制及探索治疗方案的重要性和紧迫性。由于小鼠相对于其他动物模型具有独特优势,它是研究糖尿病加速性动脉粥样硬化机制及探索有效治疗方法时使用最多的模型。在过去十年中,已建立了多种糖尿病性动脉粥样硬化小鼠模型。然而,目前尚无理想的糖尿病性动脉粥样硬化动物模型。为确定更接近人类糖尿病性动脉粥样硬化疾病的模型特征,本综述围绕以下问题聚焦于常见的糖尿病性动脉粥样硬化小鼠模型:(1)小鼠是否维持糖尿病状态;(2)糖尿病是否加速动脉粥样硬化或增加致动脉粥样硬化炎症;(3)这些因素是否对医学干预有反应。讨论旨在识别不同的糖尿病小鼠模型及其特征,以提高对合适模型的认识,这些模型可能为研究糖尿病加速性动脉粥样硬化机制和评估治疗方案提供有用工具。